Revenue
-
Net Income
-$100.0M
▼ 1.7% YoY
EPS
$-1.86
▲ 39.8% YoY
Cash
$63.0M
▲ 79.9% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Tamayo Louis Edward Chief Financial Officer | Sell | Aug 18, 2026 | 4.1K | $4.91 | $20K | Form 4 ↗ |
Townsend Richard Nolan Chief Executive Officer | Sell | Aug 18, 2026 | 3.3K | $4.95 | $17K | Form 4 ↗ |
Otero Jose Manuel Chief Operating Officer | Sell | Aug 18, 2026 | 1.3K | $4.96 | $6K | Form 4 ↗ |
Tamayo Louis Edward Chief Financial Officer | Sell | Jul 1, 2026 | 4.6K | $4.49 | $21K | Form 4 ↗ |
Otero Jose Manuel Chief Operating Officer | Sell | Jul 1, 2026 | 4.7K | $4.48 | $21K | Form 4 ↗ |
Bhalla Narinder Pal Chief Medical Officer | Sell | Jul 1, 2026 | 22.3K | $4.42 | $99K | Form 4 ↗ |
Townsend Richard Nolan Chief Executive Officer | Sell | Jul 1, 2026 | 25.9K | $4.48 | $116K | Form 4 ↗ |
Tamayo Louis Edward Chief Financial Officer | Grant | Jun 29, 2026 | 12.0K | $0.00 | $0 | Form 4 ↗ |
Otero Jose Manuel Chief Operating Officer | Grant | Jun 29, 2026 | 12.1K | $0.00 | $0 | Form 4 ↗ |
Bhalla Narinder Pal Chief Medical Officer | Grant | Jun 29, 2026 | 55.0K | $0.00 | $0 | Form 4 ↗ |
Townsend Richard Nolan Chief Executive Officer | Grant | Jun 29, 2026 | 67.0K | $0.00 | $0 | Form 4 ↗ |